These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 2243140)

  • 21. The dualistic mechanisms of platelet adhesion to von Willebrand factor substrates.
    Santoro SA
    Exp Cell Res; 1987 Dec; 173(2):413-24. PubMed ID: 3500868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib.
    Fressinaud E; Baruch D; Girma JP; Sakariassen KS; Baumgartner HR; Meyer D
    J Lab Clin Med; 1988 Jul; 112(1):58-67. PubMed ID: 2455762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor in the vessel wall mediates platelet adherence.
    Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
    Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
    Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
    J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asialo-von Willebrand factor inhibits platelet adherence to human arterial subendothelium: discrepancy between ristocetin cofactor activity and primary hemostatic function.
    Lawrence JB; Gralnick HR
    Blood; 1987 Oct; 70(4):1084-9. PubMed ID: 3115333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via alpha2 beta1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces.
    Verkleij MW; Morton LF; Knight CG; de Groot PG; Barnes MJ; Sixma JJ
    Blood; 1998 May; 91(10):3808-16. PubMed ID: 9573018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha.
    Bombeli T; Schwartz BR; Harlan JM
    J Exp Med; 1998 Feb; 187(3):329-39. PubMed ID: 9449713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI.
    Bonnefoy A; Harsfalvi J; Pfliegler G; Fauvel-Lafève F; Legrand C
    Thromb Haemost; 2001 Mar; 85(3):552-9. PubMed ID: 11307830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa.
    Parise LV; Helgerson SL; Steiner B; Nannizzi L; Phillips DR
    J Biol Chem; 1987 Sep; 262(26):12597-602. PubMed ID: 2957377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.
    de Groot PG; Ottenhof-Rovers M; van Mourik JA; Sixma JJ
    J Clin Invest; 1988 Jul; 82(1):65-73. PubMed ID: 2839553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.
    Haverstick DM; Cowan JF; Yamada KM; Santoro SA
    Blood; 1985 Oct; 66(4):946-52. PubMed ID: 3876125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor.
    Dardik R; Ruggeri ZM; Savion N; Gitel S; Martinowitz U; Chu V; Varon D
    Thromb Haemost; 1993 Sep; 70(3):522-6. PubMed ID: 8259558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
    Mondoro TH; Wall CD; White MM; Jennings LK
    Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.
    Bayer AS; Sullam PM; Ramos M; Li C; Cheung AL; Yeaman MR
    Infect Immun; 1995 Sep; 63(9):3634-41. PubMed ID: 7642301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alphaIIbbeta3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium.
    Melis E; Bonnefoy A; Daenens K; Yamamoto H; Vermylen J; Hoylaerts MF
    J Thromb Haemost; 2004 Jun; 2(6):993-1002. PubMed ID: 15140136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. von Willebrand factor and platelet interactions with the vessel wall.
    Fressinaud E; Meyer D
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):333-40. PubMed ID: 1893064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.